Synthesis and Cytotoxicity Studies of Silyl-Substituted Titanocene Dichloride Derivatives

被引:18
作者
Deally, Anthony [1 ]
Hackenberg, Frauke [1 ]
Lally, Grainne [1 ]
Mueller-Bunz, Helge [1 ]
Tacke, Matthias [1 ]
机构
[1] Univ Coll Dublin, UCD Sch Chem & Chem Biol, CSCB, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland
关键词
ANTITUMOR-ACTIVITY; TUMOR-INHIBITION; ANTIPROLIFERATIVE ACTIVITY; TITANIUM DICHLORIDE; COMPLEXES; CELLS;
D O I
10.1021/om300227h
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Six new titanocene compounds have been isolated and characterized. These compounds were synthesized from their silyl-substituted fulvene or cyclopentadiene precursors using Super Hydride (LiBEt3H) or n-BuLi, followed by transmetalation with titanium tetrachloride, to yield the corresponding titanocene dichloride derivatives. These complexes are bis-[((phenyl)dimethylsilane)cyclopentadienyl] titanium(IV) dichloride (3a), bis-[((4-methoxyphenyl)-dimethylsilane)cyclopentadienyl] titanium(IV) dichloride (3b), bis-[((4-N,N-dimethylmethanamine)dimethylsilane)cyclopentadienyl] titanium(IV) dichloride (3c), bis-[((4-N,N-diethylmethanamine)dimethylsilane)cyclopentadienyl] titanium (IV) dichloride (3d), bis-[((1-methyl-5-trimethylsilyl)indol-3-yl)methylcyclopentadienyl] titanium (IV) dichloride (4e), and bis-[((1-methyl-3-diethylaminomethyl-5-trimethylsilyl)indol-2-yl)methylcyclopentadienyl] titanium(IV) dichloride (4f). The two titanocenes 3a and 3b were crystallized and characterized by X-ray crystallography, while all six titanocenes were tested for their cytotoxicity through MTT-based in vitro tests on CAKI-1 cell lines in order to determine their IC50 values. Titanocenes were found to have IC50 values of 139 (+/- 5), 106 (+/- 4), 127 (+/- 4), 104 (+/- 9), 90 (+/- 6), and 15 (+/- 2) mu M.
引用
收藏
页码:5782 / 5790
页数:9
相关论文
共 42 条
[1]   Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs [J].
Allen, Olivia R. ;
Gott, Andrew L. ;
Hartley, John A. ;
Hartley, Janet M. ;
Knox, Richard J. ;
McGowan, Patrick C. .
DALTON TRANSACTIONS, 2007, (43) :5082-5090
[2]   Functionalized cyclopentadienyl titanium organometallic compounds as new antitumor drugs [J].
Allen, OR ;
Croll, L ;
Gott, AL ;
Knox, RJ ;
McGowan, PC .
ORGANOMETALLICS, 2004, 23 (02) :288-292
[3]  
[Anonymous], 2010, CRYSALISPRO VERS 1 1
[4]  
[Anonymous], 2011, CRYSALISPRO VERS 1 1
[5]   Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivo [J].
Bannon, J. H. ;
Fichtner, I. ;
O'Neill, A. ;
Pampillon, C. ;
Sweeney, N. J. ;
Strohfeldt, K. ;
Watson, R. W. ;
Tacke, M. ;
Mc Gee, M. M. .
BRITISH JOURNAL OF CANCER, 2007, 97 (09) :1234-1241
[6]   Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice [J].
Beckhove, Philipp ;
Oberschmidt, Olaf ;
Hanauske, Axel R. ;
Pampillon, Clara ;
Schirrmacher, Volker ;
Sweeney, Nigel J. ;
Strohfeldt, Katja ;
Tacke, Matthias .
ANTI-CANCER DRUGS, 2007, 18 (03) :311-315
[7]  
BERDEL WE, 1993, ONKOLOGIE, V16, P454
[8]   Anti-proliferative activity and mechanism of action of titanocene dichloride [J].
Christodoulou, CV ;
Eliopoulos, AG ;
Young, LS ;
Hodgkins, L ;
Ferry, DR ;
Kerr, DJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (12) :2088-2097
[9]   Benzyl-substituted titanocene dichloride anticancer drugs: From lead to hit [J].
Claffey, James ;
Mueller-Bunz, Helge ;
Tacke, Matthias .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2010, 695 (18) :2105-2117
[10]   [2.2.1]-bicyclic systems relevant to synthetic studies on CP-225,917-use of a new silylated cyclopentadiene [J].
Clive, DLJ ;
Cheng, H ;
Gangopadhyay, P ;
Huang, X ;
Prabhudas, B .
TETRAHEDRON, 2004, 60 (19) :4205-4221